(Q48148679)

English

Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

Christian Waeber

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

author name string

Cutrer FM

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

Yu XJ

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

Ayata G

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

Moskowitz MA

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

38

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

7

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

1043-1053

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

The pre- and postjunctional activity of CP-122,288, a conformationally restricted analogue of sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Serotonin-5-O-carboxymethyl-glycyl[125I]tyrosinamide labels the 5-HT1D beta receptor subtype in human cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

A subfamily of 5-HT1D receptor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Mode of action of the anti-migraine drug sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Ergovaline binding and activation of D2 dopamine receptors in GH4ZR7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175).

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Wolff Award presentation 1993. Anti-migraine drug interactions with cloned human 5-hydroxytryptamine1 receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Cloning and characterisation of the human 5-HT5A serotonin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

GR127935: a potent and selective 5-HT1D receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Focal ischemia in rats causes time-dependent expression of c-fos protein immunoreactivity in widespread regions of ipsilateral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Expression of serotonin receptor mRNAs in blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Neuropeptides and Mast Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900032-5

7 January 2021

Identifiers

10.1016/S0028-3908(99)00032-5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

release_o7ro6fy4y5hsjc4uusaj7gu4bm

1 reference

https://api.fatcat.wiki/v0/release/o7ro6fy4y5hsjc4uusaj7gu4bm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428423

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48148679&oldid=2187719656"